KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Income from Continuing Operations (2016 - 2025)

Charles River Laboratories International has reported Income from Continuing Operations over the past 17 years, most recently at 276290000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 29.26% year-over-year to 276290000.0; the TTM value through Dec 2025 reached 142163000.0, down 662.11%, while the annual FY2025 figure was 142163000.0, 662.11% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 276290000.0 at Charles River Laboratories International, down from 55556000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 189106000.0 in Q4 2022 and troughed at 276290000.0 in Q4 2025.
  • A 5-year average of 62747150.0 and a median of 92088500.0 in 2021 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: surged 48.94% in 2022 and later plummeted 213.12% in 2024.
  • Year by year, Income from Continuing Operations stood at 139827000.0 in 2021, then skyrocketed by 35.24% to 189106000.0 in 2022, then dropped by 0.08% to 188952000.0 in 2023, then plummeted by 213.12% to 213747000.0 in 2024, then dropped by 29.26% to 276290000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CRL at 276290000.0 in Q4 2025, 55556000.0 in Q3 2025, and 52693000.0 in Q2 2025.